StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
IBAC

IB Acquisition Corp.

IBAC Nasdaq Services-Commercial Physical & Biological Research EDGAR ↗
$11.10
-0.20 -1.77%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$55.6M
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
-$400K
EPS (TTM) ⓘ
—
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
$30.2K
Total assets ⓘ
$8.52M
Gross margin ⓘ
—
52-week range ⓘ
$10.19 – $11.64

AI briefing

from the latest 10-K, 10-Q and 8-K events

IB Acquisition Corp. is a blank check company seeking a business combination, now under a merger agreement with GNQ Insilico Inc.

What they do

IB Acquisition Corp. is a special purpose acquisition company (SPAC) formed to effect a merger, share exchange, or similar business combination with one or more businesses. The company has no specific sector focus but plans to target businesses in consumer goods, sports and entertainment, and healthcare technology, with enterprise values of at least $500 million. As of the latest 10-Q, the company had not yet completed a business combination and held cash and equivalents of $30,161 as of June 30, 2026.

Revenue drivers

  • No operating revenue — The company is a blank check company with no operations or revenue; it has not generated any revenue from business activities.

Recent performance

For fiscal year 2025, the company reported net income of $3.4 million, up from $1.9 million in 2024, while operating cash flow was negative $1.3 million. As of June 30, 2026, total assets were $8.5 million, total liabilities $2.4 million, and shareholder equity was negative $2.3 million. The company's cash and equivalents were only $30,161 at that date, indicating a reliance on external funding or the trust account.

Strategy

The company intends to complete a business combination using proceeds from its IPO and private placement units. On March 16, 2026, it entered into a Business Combination Agreement with GNQ Insilico Inc., a Canadian company, involving a share exchange structure with exchangeable shares for Canadian shareholders and SPAC Class A common stock for others. The company expects to incur significant costs in pursuing this acquisition and may require additional financing to complete the transaction.

Risks

  • Going concern risk — The company has limited cash outside the trust account and negative shareholder equity, raising substantial doubt about its ability to continue as a going concern.
  • Business combination may not close — The proposed GNQ Business Combination is subject to court approval and other closing conditions, and there is no assurance it will be completed within the combination period ending March 28, 2026.
  • Shareholder redemptions may reduce funds — Public stockholders may exercise redemption rights, which could significantly reduce the cash available in the trust account and impair the company's ability to complete the business combination.
  • Cross-border and exchangeable-share complexity — The exchangeable-share structure of the GNQ transaction is complex and may present legal, regulatory, and tax risks that could delay or prevent closing.

Outlook

Management expects to continue incurring significant costs in pursuing the GNQ Business Combination and may need additional financing. The combination period ends on March 28, 2026, unless extended, and the company is subject to ongoing risks including redemptions and financing shortfalls. The company's ability to complete the business combination is uncertain, and if not completed, it may be forced to liquidate.

Recent SEC filings

40 most recent
Annual, quarterly & current reports
Other filings
SCHEDULE 13G/A Apr 8, 2026
SCHEDULE 13G/A Feb 12, 2026
SCHEDULE 13G/A Feb 12, 2026
SCHEDULE 13G/A Feb 11, 2026
SCHEDULE 13G/A Nov 14, 2025